Yoga for Back Pain in Adolescent Scoliosis
The Problem: Adolescent Idiopathic Scoliosis (AIS), the pre-eminent spinal pathology affecting over 5% of children and adolescents, presents a pronounced spinal curvature exceeding 10 degrees, with prevalence amongst female adolescents at a ratio of 3:1 compared to males. A significant portion of these patients are not
| Condition(s) | Scoliosis Idiopathic Adolescent Treatment, Scoliosis Idiopathic, Scoliosis; Adolescence, Scoliosis |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The Problem: Adolescent Idiopathic Scoliosis (AIS), the pre-eminent spinal pathology affecting over 5% of children and adolescents, presents a pronounced spinal curvature exceeding 10 degrees, with prevalence amongst female adolescents at a ratio of 3:1 compared to males. A significant portion of these patients are not immediate candidates for surgical intervention. The acute shortage of viable non-operative management strategies, which is becoming increasingly imperative given the current barriers to physical therapy access and the growing opioid crisis. The investigator's research intends to explore the addition of a structured yoga protocol to standard of care. This research will thus explore the potential for improved relief and quality-of-life improvements for AIS patients not ready f |
| Who can participate | Inclusion Criteria: * Non-operatively treated AIS patients at Johns Hopkins Hospital with back pain who are candidates for physical therapy. * Cobb angle: greater than 25 degrees, * Visual Analog Scale (VAS) Pain score greater than 41/0 * Braced and Unbraced Patients Exclusion Criteria: * Scoliosis due to causes other than AIS. * AIS patients who have undergone surgery for scoliosis or back pain * Age less than 10 years of age or greater than 20 years of age * Unable to access zoom on any electronic device |
| Ages | 10 Years to 20 Years |
| Sex | All |
| Lead sponsor | Johns Hopkins University |
| Locations | Baltimore, Maryland, United States |
| Start date | 2025-01-01 |
| NCT ID | NCT06242821 |
| Official listing | https://clinicaltrials.gov/study/NCT06242821 |